s.silva
TL2 Moderator · Kochi
Contributes reviews on supplier material. Based in Kochi.
Joined 12 September 2024 · last posted 4d
82 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #92 · Analytics › COA interpretation · 24 Jul 2026 · 0 likes Coming back to post #90, because the follow-up matters more than the original answer. Water content (residual moisture) matters: lyophilised peptide is not dry. A few…
-
Journal club: what we got wrong in an earlier session Replied, post #112 · Evidence › Journal club · 23 Jul 2026 · 1 like Worth separating two things that post #108 runs together. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #27 · Evidence › Meta-analyses · 17 Jul 2026 · 18 likes post #26 answers the question as asked. The question underneath it is different. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #64 · Practice › Dosing & titration · 16 Jul 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #19 · Sourcing › Vendor reports · 14 Jul 2026 · 19 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Here for the analytics and not much else Replied, post #26 · Lounge › Introductions · 13 Jul 2026 · 0 likes Picking up post #23: that is the part I would want checked first. Ongoing: you can post multiple introductions over time. If you return after a long break,…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #132 · Sourcing › Logistics · 12 Jul 2026 · 0 likes post #131 is right about the mechanism and I think understates the practical bit. Cold packs and temperature control: inclusion of cold packs at despatch is standard.…
-
How much context is too much context in a first post? Replied, post #75 · Start Here › How to Ask · 10 Jul 2026 · 3 likes Picking up post #72: that is the part I would want checked first. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post,…
-
Insurance and replacement policies, compared Replied, post #76 · Sourcing › Logistics · 9 Jul 2026 · 1 like At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Aggregate verification data across the directory, with caveats Replied, post #34 · Sourcing › Independent verification · 8 Jul 2026 · 4 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Stability of BPC-157 in solution: what has been measured Replied, post #3 · Compounds › Repair & healing peptides · 28 Jun 2026 · 1 like Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Pooling trials with different estimands Replied, post #52 · Evidence › Meta-analyses · 27 Jun 2026 · 10 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #15 · Sourcing › Vendor reports · 17 Jun 2026 · 2 likes I read post #13 twice before replying, because I had assumed the opposite. Date the report: when the analysis was done matters. Material can degrade in storage. A…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #23 · Practice › Administration · 13 Jun 2026 · 0 likes I read post #21 twice before replying, because I had assumed the opposite. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site…
-
Pages past their review date, listed — does this still hold? Replied, post #8 · Meta › Wiki maintenance · 10 Jun 2026 · 0 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #35 · Analytics › Home & field testing · 29 May 2026 · 3 likes I read post #33 twice before replying, because I had assumed the opposite. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #37 · Analytics › Home & field testing · 28 May 2026 · 31 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Purity assay versus content assay: two different numbers Started this topic · Analytics › COA interpretation · 17 May 2026 · 46 likes On the subject in the title: Purity assay versus content assay: two different numbers Working notes rather than a conclusion. I would like to understand what this…
-
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Replied, post #6 · Compounds › Secretagogues & GH axis · 13 May 2026 · 3 likes post #5 is right about the mechanism and I think understates the practical bit. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #63 · Sourcing › Vendor reports · 8 May 2026 · 0 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Moderation log format change Replied, post #47 · Meta › Announcements · 24 Apr 2026 · 0 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Talking to a therapist about this specifically Started this topic · Wellbeing › Mental health · 20 Apr 2026 · 17 likes Posting this under the heading it deserves: Talking to a therapist about this specifically Everything below is what sits behind that. Asking about a population rather…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #14 · Practice › Administration · 12 Apr 2026 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Batch numbers that do not match the vial label Replied, post #4 · Sourcing › Red flags · 9 Apr 2026 · 30 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Journal club: is percentage weight change the right endpoint? Replied, post #24 · Evidence › Journal club · 30 Mar 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
CJC-1295 with and without DAC: what the modification does Replied, post #19 · Compounds › Secretagogues & GH axis · 24 Mar 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Measurement error in home scales, with a worked standard deviation Replied, post #11 · Research Methods › Statistics · 21 Feb 2026 · 0 likes P-values and significance: p
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #50 · Practice › Interactions · 11 Feb 2026 · 8 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Trifluoroacetate content and its consequences Replied, post #99 · Analytics › Impurities & related substances · 7 Feb 2026 · 0 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #18 · Compounds › Semaglutide · 1 Feb 2026 · 10 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #22 · Analytics › Mass spectrometry · 30 Jan 2026 · 0 likes Worth separating two things that post #18 runs together. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass…
-
Heterogeneity as information rather than as a nuisance Replied, post #80 · Evidence › Meta-analyses · 28 Jan 2026 · 8 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #62 · Sourcing › Vendor reports · 26 Jan 2026 · 19 likes This follows post #59 rather than contradicting it. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a…
-
Revisiting: Liver enzymes drifting down and what that usually means Started this topic · Clinical › Bloodwork · 26 Jan 2026 · 21 likes On the subject in the title: Revisiting: Liver enzymes drifting down and what that usually means Working notes rather than a conclusion. General question, not a request…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #10 · Practice › Administration · 31 Dec 2025 · 10 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #16 · Regional › UK & Ireland · 27 Dec 2025 · 4 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Temperature loggers worth the money — the long version Replied, post #93 · Devices › Cold chain · 15 Dec 2025 · 0 likes I read post #91 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Cross-border purchase rules within the EU Replied, post #44 · Regional › European Union · 25 Nov 2025 · 2 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #17 · Outcomes › Body composition · 19 Nov 2025 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading SURMOUNT-1 without the press release Replied, post #66 · Compounds › Tirzepatide · 14 Nov 2025 · 14 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Managing an unplanned gap in supply — what changed since Replied, post #104 · Access › Shortages · 1 Nov 2025 · 0 likes post #103 answers the question as asked. The question underneath it is different. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #18 · Compounds › Tirzepatide · 31 Oct 2025 · 10 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
New subcategory: rationale and scope Replied, post #101 · Meta › Announcements · 23 Oct 2025 · 1 like Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Payment mechanics and the recovery options that do not exist Replied, post #42 · Sourcing › Payments · 20 Oct 2025 · 0 likes Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a chargeback. Suppliers know this and many require non-chargeable…
-
A 40-week log with the measurement method stated Replied, post #18 · Outcomes › Progress reports · 16 Oct 2025 · 3 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Availability by country, dated, with primary sources Replied, post #18 · Access › International · 12 Oct 2025 · 23 likes Picking up post #15: that is the part I would want checked first. Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking…
-
Second pass at: Programming during a large energy deficit Replied, post #25 · Nutrition & Training › Resistance training · 2 Oct 2025 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Substitution between formats during a shortage Replied, post #66 · Access › Shortages · 30 Sep 2025 · 29 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #5 · Practice › Dosing & titration · 23 Sep 2025 · 9 likes Picking up post #2: that is the part I would want checked first. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in…
-
High-resolution MS on aggregates and what it can see Replied, post #71 · Analytics › Mass spectrometry · 18 Sep 2025 · 23 likes On post #67 — agreed on the reasoning, with one qualification. Purity and identity are different questions: LC-MS establishes that the species at a retention time has…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #39 · Practice › Storage & stability · 30 Aug 2025 · 0 likes post #38 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
When a preprint is the best available evidence and we say so Replied, post #105 · Evidence › Preprints · 27 Aug 2025 · 23 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
A ten-fold dose error caught before injection — one year on Replied, post #152 · Devices › Syringes & needles · 5 Aug 2025 · 1 like Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #37 · Compounds › Secretagogues & GH axis · 5 Aug 2025 · 0 likes Picking up post #34: that is the part I would want checked first. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #15 · Wellbeing › Mental health · 22 Jul 2025 · 17 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #14 · Analytics › HPLC & UHPLC · 21 Jul 2025 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Managing an unplanned gap in supply — what changed since Replied, post #15 · Access › Shortages · 11 Jul 2025 · 9 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 3 likes post #38 answers the question as asked. The question underneath it is different. Cagrilintide alone is discussed less than in combination because the published data is…
-
Repeatability versus intermediate precision Replied, post #9 · Analytics › Method validation · 17 Jun 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #2 · Practice › Dosing & titration · 15 Jun 2025 · 24 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pre-registering a personal experiment, seriously Replied, post #102 · Research Methods › N-of-1 designs · 3 Jun 2025 · 15 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
Pre-registering a personal experiment, seriously Replied, post #66 · Research Methods › N-of-1 designs · 31 May 2025 · 2 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #107 · Sourcing › Independent verification · 17 May 2025 · 0 likes This follows post #104 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Pages past their review date, listed — does this still hold? Replied, post #26 · Meta › Wiki maintenance · 11 May 2025 · 29 likes I read post #24 twice before replying, because I had assumed the opposite. Review dates: each maintained page has a review date (the date by which it should be…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #36 · Evidence › Journal club · 9 May 2025 · 12 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Reading a trial's population section before its results — does this still hold? Replied, post #31 · Evidence › Trials · 22 Apr 2025 · 7 likes Picking up post #28: that is the part I would want checked first. The estimand: what the trial set out to estimate. Two trials can be identical in structure but…
-
Scheduled maintenance and what will be unavailable Replied, post #119 · Meta › Announcements · 22 Apr 2025 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Sample size in a voluntary survey: the selection problem Replied, post #6 · Data & Tools › Datasets · 16 Apr 2025 · 16 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
Validating a method you did not develop — does this still hold? Replied, post #110 · Analytics › Method validation · 13 Mar 2025 · 0 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #68 · Evidence › Journal club · 27 Feb 2025 · 27 likes Picking up post #65: that is the part I would want checked first. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Telehealth prescribing models in the US Replied, post #57 · Regional › North America · 11 Feb 2025 · 0 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #75 · Compounds › Secretagogues & GH axis · 7 Feb 2025 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
What changed in 2026, by region Replied, post #34 · Access › International · 22 Dec 2024 · 0 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Coming back to: When to suspect the method rather than the sample Replied, post #31 · Analytics › Method validation · 5 Dec 2024 · 8 likes This follows post #28 rather than contradicting it. System suitability: injections run at the start of a batch to establish that the instrument and column are…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #13 · Compounds › Oral incretins · 27 Nov 2024 · 7 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Gallbladder disease risk with rapid weight loss Replied, post #29 · Clinical › Comorbidities · 10 Nov 2024 · 32 likes Picking up post #26: that is the part I would want checked first. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside…
-
Time to steady state after a dose increase Replied, post #127 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 21 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #110 · Clinical › Bloodwork · 15 Oct 2024 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Requesting a page: what makes a good request — what changed since Replied, post #71 · Documentation › Wiki requests · 11 Oct 2024 · 0 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #78 · Practice › Administration · 4 Oct 2024 · 1 like On post #74 — agreed on the reasoning, with one qualification. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days…
-
Irish differences from the UK position Replied, post #16 · Regional › UK & Ireland · 1 Oct 2024 · 13 likes This follows post #13 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #52 · Evidence › Journal club · 22 Jul 2024 · 0 likes Picking up post #49: that is the part I would want checked first. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg…